S

SC II Acquisition Corp. Right

0.23-7.16 %$SCIIR
NASDAQ

Price History

-14.07%

SC II Acquisition Corp. Right is a financial instrument issued as part of the units in SC II Acquisition Corp.'s initial public offering. Each unit, priced at $10.00, consists of one Class A ordinary share and one right, entitling the holder to receive one-fifth (1/5) of a Class A ordinary share upon the completion of the company's initial business combination. As a blank check company, or special purpose acquisition company (SPAC), SC II Acquisition Corp. was formed to effect a merger, share exchange, asset acquisition, or similar business combination with one or more target businesses in any industry or geographic location. Commencing January 20, 2026, holders may separate units to trade rights independently, providing flexibility for investors to manage positions separately from shares. Sponsored by Nukkleus Defense Technologies, Inc., a subsidiary of Nukkleus Inc., these rights play a key role in SPAC structures by offering potential equity upside contingent on a successful de-SPAC transaction, enhancing liquidity and strategic trading options within the public markets.

Company Overview

SC II Acquisition Corp. Right is a financial instrument issued as part of the units in SC II Acquisition Corp.'s initial public offering. Each unit, priced at $10.00, consists of one Class A ordinary share and one right, entitling the holder to receive one-fifth (1/5) of a Class A ordinary share upon the completion of the company's initial business combination. As a blank check company, or special purpose acquisition company (SPAC), SC II Acquisition Corp. was formed to effect a merger, share exchange, asset acquisition, or similar business combination with one or more target businesses in any industry or geographic location. Commencing January 20, 2026, holders may separate units to trade rights independently, providing flexibility for investors to manage positions separately from shares. Sponsored by Nukkleus Defense Technologies, Inc., a subsidiary of Nukkleus Inc., these rights play a key role in SPAC structures by offering potential equity upside contingent on a successful de-SPAC transaction, enhancing liquidity and strategic trading options within the public markets.